These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 17061890)

  • 1. Conformational flexibility, internal hydrogen bonding, and passive membrane permeability: successful in silico prediction of the relative permeabilities of cyclic peptides.
    Rezai T; Bock JE; Zhou MV; Kalyanaraman C; Lokey RS; Jacobson MP
    J Am Chem Soc; 2006 Nov; 128(43):14073-80. PubMed ID: 17061890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testing the conformational hypothesis of passive membrane permeability using synthetic cyclic peptide diastereomers.
    Rezai T; Yu B; Millhauser GL; Jacobson MP; Lokey RS
    J Am Chem Soc; 2006 Mar; 128(8):2510-1. PubMed ID: 16492015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient solid-phase synthesis of a series of cyclic and linear peptoid-dexamethasone conjugates for the cell permeability studies.
    Cho S; Choi J; Kim A; Lee Y; Kwon YU
    J Comb Chem; 2010 May; 12(3):321-6. PubMed ID: 20210299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular dynamics simulation in vacuo and in solution of cyclolinopeptide A: a conformational study.
    Saviano M; Aida M; Corongiu G
    Biopolymers; 1991 Jul; 31(8):1017-24. PubMed ID: 1782353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between structure and high-throughput screening permeability of diverse drugs with artificial membranes: application to prediction of Caco-2 cell permeability.
    Fujikawa M; Ano R; Nakao K; Shimizu R; Akamatsu M
    Bioorg Med Chem; 2005 Aug; 13(15):4721-32. PubMed ID: 15936203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of structure-lipid bilayer permeability relationships for peptide-like small organic molecules.
    Cao Y; Xiang TX; Anderson BD
    Mol Pharm; 2008; 5(3):371-88. PubMed ID: 18355031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Searching the conformational space of cyclic beta-amino acid peptides.
    Sussman F; Villaverde MC; Estévez JC; Estévez RJ
    J Phys Chem B; 2009 Jul; 113(29):9669-80. PubMed ID: 19555098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting the conformational states of cyclic tetrapeptides.
    Loiseau N; Gomis JM; Santolini J; Delaforge M; André F
    Biopolymers; 2003 Jul; 69(3):363-85. PubMed ID: 12833263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative comparison of the relative cell permeability of cyclic and linear peptides.
    Kwon YU; Kodadek T
    Chem Biol; 2007 Jun; 14(6):671-7. PubMed ID: 17584614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond cyclosporine A: conformation-dependent passive membrane permeabilities of cyclic peptide natural products.
    Ahlbach CL; Lexa KW; Bockus AT; Chen V; Crews P; Jacobson MP; Lokey RS
    Future Med Chem; 2015; 7(16):2121-30. PubMed ID: 26067057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid composition effect on permeability across PAMPA.
    Seo PR; Teksin ZS; Kao JP; Polli JE
    Eur J Pharm Sci; 2006 Nov; 29(3-4):259-68. PubMed ID: 16781125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The conformation of cyclo(-D-Pro-Ala4-) as a model for cyclic pentapeptides of the DL4 type.
    Heller M; Sukopp M; Tsomaia N; John M; Mierke DF; Reif B; Kessler H
    J Am Chem Soc; 2006 Oct; 128(42):13806-14. PubMed ID: 17044709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Permeation prediction of M100240 using the parallel artificial membrane permeability assay.
    Hwang KK; Martin NE; Jiang L; Zhu C
    J Pharm Pharm Sci; 2003; 6(3):315-20. PubMed ID: 14738711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parallel artificial membrane permeability assay: a new membrane for the fast prediction of passive human skin permeability.
    Ottaviani G; Martel S; Carrupt PA
    J Med Chem; 2006 Jun; 49(13):3948-54. PubMed ID: 16789751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parallel artificial membrane permeability assay (PAMPA) combined with a 10-day multiscreen Caco-2 cell culture as a tool for assessing new drug candidates.
    Masungi C; Mensch J; Van Dijck A; Borremans C; Willems B; Mackie C; Noppe M; Brewster ME
    Pharmazie; 2008 Mar; 63(3):194-9. PubMed ID: 18444507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A hydrogen-bonding-modulated molecular rotor: environmental effect in the conformational stability of peptidomimetic macrocyclic cyclophanes.
    Alfonso I; Burguete MI; Luis SV
    J Org Chem; 2006 Mar; 71(6):2242-50. PubMed ID: 16526769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Passive Membrane Permeability in Cyclic Peptomer Scaffolds Is Robust to Extensive Variation in Side Chain Functionality and Backbone Geometry.
    Furukawa A; Townsend CE; Schwochert J; Pye CR; Bednarek MA; Lokey RS
    J Med Chem; 2016 Oct; 59(20):9503-9512. PubMed ID: 27690434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flexibility versus Rigidity for Orally Bioavailable Cyclic Hexapeptides.
    Nielsen DS; Lohman RJ; Hoang HN; Hill TA; Jones A; Lucke AJ; Fairlie DP
    Chembiochem; 2015 Nov; 16(16):2289-93. PubMed ID: 26336864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Permeability through DOPC/dodecane membranes: measurement and LFER modelling.
    Huque FT; Box K; Platts JA; Comer J
    Eur J Pharm Sci; 2004 Nov; 23(3):223-32. PubMed ID: 15489123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationalization of the Membrane Permeability Differences in a Series of Analogue Cyclic Decapeptides.
    Witek J; Wang S; Schroeder B; Lingwood R; Dounas A; Roth HJ; Fouché M; Blatter M; Lemke O; Keller B; Riniker S
    J Chem Inf Model; 2019 Jan; 59(1):294-308. PubMed ID: 30457855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.